Remibrutinib Decreases Urticaria Disease Activity Leading To Improved Disease Control: An Analysis From The REMIX-1/-2 Studies

Journal of Allergy and Clinical Immunology 2026

View at publisher
Authors: Sarbjit S. Saini, Vipul Jain, Eric J. Boren, Huiping Wang, Hidetoshi Takahashi, Nadine Chapman‐Rothe, Sibylle P. Hämmerle, George Vamvakas, Martin Metz
DOI: 10.1016/j.jaci.2025.12.828
Cited by: 0

Fields of Study & Subjects

Urticaria and Related Conditions Mast cells and histamine Dermatology and Skin Diseases

Publication details

Journal / source
Journal of Allergy and Clinical Immunology
Volume
157
Issue
2
Pages
AB277–AB277
Publication date
1 February 2026
Language
EN